Features
Group captives continue to thrive and George Rusu and Nick Hentges should take credit for...
MORE
Corporate failures are not common, but can be disruptive. How certain is the captive's future...
MORE
London & Capital’s hire of Kate Miller has refocused the firm on its European offering. ...
MORE
Our cover feature this month strikes at the heart of a captive’s intrinsic link to...
MORE
Pulling together the annual Captive Review Power 50 is not an easy task, but it...
MORE
Brian Quinn, managing director at Granite Management Limited in Bermuda, discusses the evolution of employee...
MORE
A joint health insurance venture between Amazon, Berkshire Hathaway and JPMorgan Chase & Co., has...
MORE
A full analysis of global captive insurance statistics is at least a month away, but...
MORE
Brian First, EVP of Arch Insurance Group, discusses evolution and trends in the group captive...
MORE
Malcolm Cutts-Watson, an independent consultant and member of the Labuan Financial Services Authority’s International Advisory...
MORE

John Keating joins Coca-Cola European Partners

John Keating has joined the risk and insurance team at Coca-Cola European Partners (CCEP) as associate director, risk...
MORE

Hong Kong has captive potential, but tax changes not a “game changer”

The tax changes tipped to encourage captive formations in Hong Kong is unlikely to have the desired effect, according to Jonathan Culver, leader of Deloitte’s financial services tax...
MORE

Three captives in, 29 out of BVI

The British Virgin Islands licensed three new captives in 2017, while 29 captives surrendered their licence. The high number of surrendered licences follows a trend across offshore and...
MORE

Pfizer captive rated ‘Excellent’

The Vermont captive owned by pharmaceutical giant Pfizer has had its financial strength rating of ‘A’ (Excellent) affirmed by A.M. Best. Blue Whale Re Ltd writes Pfizer’s global...
MORE